BCR and chronic myelogenous leukemia, BCR-ABL1 positive: In CML cells, PP2A is a key target in BCR–ABL1 downstream signaling and, in fact, the BCR–ABL1 oncoprotein prevents PP2A auto-dephosphorylation at tyrosine 307 (44, 45) thereby keeping PP2A in its inactive status.